Overweight and hypertension : a 2-way street?
暂无分享,去创建一个
[1] J. Cutler,et al. Obesity and hypertension: epidemiological and clinical issues. , 1987, European heart journal.
[2] O. Bertel,et al. Decreased Beta‐Adrenoreceptor Responsiveness as Related to Age, Blood Pressure, and Plasma Catecholamines in Patients with Essential Hypertension , 1980, Hypertension.
[3] B. Saltin,et al. The metabolic and circulatory response to beta-blockade in hypertensive men is correlated to muscle capillary density. , 1992, Blood pressure.
[4] J. Stamler,et al. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. , 1978, JAMA.
[5] S. Kjeldsen,et al. Sympathetic Nervous System Involvement in Essential Hypertension: Increased Platelet Noradrenaline Coincides with Decreased β-Adrenoreceptor Responsiveness , 1994 .
[6] J. Stamler,et al. Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS). , 1995, Preventive medicine.
[7] V. Campese,et al. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. , 1982, Kidney international.
[8] S. Julius,et al. The hemodynamic link between insulin resistance and hypertension. , 1991, Journal of hypertension.
[9] P. Korner,et al. Contribution of cardiovascular reflexes to differences in beta-adrenoceptor-mediated responses in essential hypertension. , 1981, Clinical science.
[10] R. Schwartz,et al. Reduced metabolic rate during beta-adrenergic blockade in humans. , 1991, Metabolism: clinical and experimental.
[11] J. Bülow,et al. Thermogenic response to epinephrine in the forearm and abdominal subcutaneous adipose tissue. , 1992, The American journal of physiology.
[12] M. S. Leaning,et al. Analytical Review , 2020, 1789.
[13] E. Ravussin,et al. Skeletal muscle metabolism is a major determinant of resting energy expenditure. , 1990, The Journal of clinical investigation.
[14] R. Schwartz,et al. Reduced metabolic rate during β-adrenergic blockade in humans☆ , 1991 .
[15] S. Silberstein,et al. Sympathetic nervous system activity and the thermic effect of feeding in man. , 1987, International journal of obesity.
[16] L. Landsberg,et al. Sympathoadrenal system and regulation of thermogenesis. , 1984, The American journal of physiology.
[17] G Mancia,et al. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. , 1998, Hypertension.
[18] W. Kannel,et al. The relation of adiposity to blood pressure and development of hypertension. The Framingham study. , 1967, Annals of internal medicine.
[19] G. Paolisso,et al. Glucose ingestion affects cardiac ANS in healthy subjects with different amounts of body fat. , 1997, The American journal of physiology.
[20] M. White,et al. Age, hypertension, and cardiac responses to β‐agonist in humans , 1998 .
[21] C. Stein,et al. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. , 1995, The Journal of clinical investigation.
[22] L. Landsberg. Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. , 1986, The Quarterly journal of medicine.
[23] J Miura,et al. [Obesity and hypertension]. , 1992, Nihon rinsho. Japanese journal of clinical medicine.
[24] A. Hill,et al. Serotoninergic modulation of the pattern of eating and the profile of hunger-satiety in humans. , 1987, International journal of obesity.
[25] M. Caron,et al. Turning off the signal: desensitization of β‐adrenergic receptor function , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] R. Feldman,et al. Low sodium diet corrects the defect in lymphocyte beta-adrenergic responsiveness in hypertensive subjects. , 1987, The Journal of clinical investigation.
[27] R. Townsend,et al. Lipolytic sensitivity and response to fasting in normotensive and hypertensive obese humans. , 1997, Metabolism: clinical and experimental.
[28] S. Toubro,et al. Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[29] S. Nesbitt,et al. Parental hyperdynamic circulation predicts insulin resistance in offspring: The Tecumseh Offspring Study. , 1999, Hypertension.
[30] V. Stevens,et al. Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.
[31] E. Ravussin,et al. Thermic effect of glucose in man. Obligatory and facultative thermogenesis. , 1984, The Journal of clinical investigation.
[32] D. Goldstein,et al. Plasma catecholamines and essential hypertension. An analytical review. , 1983, Hypertension.
[33] J. Giacobino,et al. Beta 3-adrenoceptor: an update. , 1995, European journal of endocrinology.
[34] P. Vokonas,et al. Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. , 1990, Annals of epidemiology.
[35] S. Welle,et al. Thermic effect of feeding in man: increased plasma norepinephrine levels following glucose but not protein or fat consumption. , 1981, Metabolism: clinical and experimental.
[36] M. Blaufox,et al. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. , 1992, Archives of internal medicine.
[37] P. Nestel,et al. Noradrenaline turnover during under- and over-eating in normal weight subjects. , 1982, Metabolism: clinical and experimental.
[38] S. Julius,et al. Role of Parasympathetic Inhibition in the Hyperkinetic Type of Borderline Hypertension , 1971, Circulation.
[39] R. DeFronzo,et al. Effect of beta and alpha adrenergic blockade on glucose-induced thermogenesis in man. , 1984, The Journal of clinical investigation.
[40] W. Saris,et al. Adrenoceptor subtypes mediating catecholamine-induced thermogenesis in man. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[41] E A Anderson,et al. Elevated Sympathetic Nerve Activity in Borderline Hypertensive Humans Evidence From Direct Intraneural Recordings , 1989, Hypertension.
[42] M. Condorelli,et al. Studies of the mechanisms underlying impairment of beta-adrenoceptor-mediated effects in human hypertension. , 1983, Hypertension.
[43] Tataranni Pa. From physiology to neuroendocrinology: a reappraisal of risk factors of body weight gain in humans. , 1998 .
[44] N. Schork,et al. Hyperkinetic borderline hypertension in Tecumseh, Michigan , 1991, Journal of hypertension.
[45] S. Julius,et al. Altered Cardiac Responsiveness and Regulation in the Normal Cardiac Output Type of Borderline Hypertension , 1975, Circulation research.
[46] C. Furberg,et al. Long term propranolol treatment and changes in body weight after myocardial infarction. , 1990, BMJ.
[47] V. Somers,et al. An independent relationship between plasma leptin and heart rate in untreated patients with essential hypertension. , 1999, Journal of hypertension.
[48] E. Ravussin,et al. A brief overview of human energy metabolism and its relationship to essential obesity. , 1992, The American journal of clinical nutrition.
[49] M. Lohse,et al. Molecular mechanisms of membrane receptor desensitization. , 1993, Biochimica et biophysica acta.
[50] M. Goran,et al. Sympathetic nervous system activity, body fatness, and body fat distribution in younger and older males. , 1995, Journal of applied physiology.
[51] J. Bülow,et al. Contribution of skeletal muscle and adipose tissue to adrenaline-induced thermogenesis in man. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[52] G. Jennings,et al. Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension. , 1997, Clinical and experimental hypertension.
[53] A. Astrup,et al. Facultative thermogenesis induced by carbohydrate: a skeletal muscle component mediated by epinephrine. , 1986, The American journal of physiology.
[54] P. Vollenweider,et al. Body fat and sympathetic nerve activity in healthy subjects. , 1994, Circulation.
[55] A. Astrup,et al. Contribution of BAT and skeletal muscle to thermogenesis induced by ephedrine in man. , 1985, The American journal of physiology.
[56] L. Landsberg,et al. Stimulation of the sympathetic nervous system during sucrose feeding , 1977, Nature.
[57] S. Julius,et al. Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. , 1994, Journal of hypertension.
[58] L. Sjöström,et al. Epinephrine sensitivity with respect to metabolic rate and other variables in women. , 1983, The American journal of physiology.
[59] E Casiglia,et al. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. , 1997, Hypertension.
[60] N. Schork,et al. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study. , 1990, JAMA.
[61] L. Landsberg,et al. Suppression of sympathetic nervous system during fasting. , 1997, Obesity research.
[62] J. Tuomilehto,et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. , 1987, Journal of hypertension.
[63] G. Reaven,et al. Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.
[64] I. Macdonald,et al. Catecholamines and the control of metabolism in man. , 1985, Clinical science.
[65] S Cerutti,et al. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability. , 1988, Journal of hypertension.
[66] F. Messerli,et al. Plasma Cyclic Adenosine 3':5' ‐Monophosphate Response to Isoproterenol and Glucagon in Hyperkinetic Borderline (Labile) Hypertension , 1976, Circulation research.
[67] Rudolph L. Leibel,et al. Medical progress: Obesity. , 1997 .
[68] T. Kotchen,et al. Peripheral beta-receptor responsiveness in patients with essential hypertension. , 1979, Archives of internal medicine.
[69] G. Jennings,et al. Biochemical evidence of sympathetic hyperactivity in human hypertension. , 1991, Hypertension.
[70] R. Leibel,et al. Autonomic nervous system activity in weight gain and weight loss. , 1995, The American journal of physiology.
[71] R. Feldman. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. , 1990, The Journal of clinical investigation.